High Vista Strategies LLC Novavax Inc Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $669,839 - $1.09 Million	-4,978 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $21,869 - $33,281	-123 Reduced 2.41%	4,978 $1.03 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $212,960 - $453,499	1,760 Added 52.68%	5,101 $1.08 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $269,005 - $761,753	-2,381 Reduced 41.61%	3,341 $606,000
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $450,550 - $798,219	5,722 New	5,722 $638,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.